Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2013 / Cilt: 47 - Sayı: 3

Retrospective analysis of 27 patients with cutaneous sarcoidosis

Kutanöz sarkoidozlu 27 hastanın retrospektif analizi

Pages
148–154
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, all patients presenting to the dermatology departments with cutaneous sarcoidosis require investigations for systemic sarcoidosis. (Turkderm 2013; 47: 148-54)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Sarcoidosis is a multisystem disorder of unknown etiology, characterized by noncaseating granulomas involving especially the lungs, reticuloendothelial system, eyes and skin.
📊
Key Findings & Data:Although skin involvement has been reported in 9-37% of patients with sarcoidosis, isolated skin involvement has been reported in only 5.4%-13.8% of the cases.
💡
Conclusion & Impact:Therefore, all patients presenting to the dermatology departments with cutaneous sarcoidosis require investigations for systemic sarcoidosis. (Turkderm 2013; 47: 148-54)
🔬Design:Review & Systematic Survey
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Sarcoidosis is a multisystem disorder of unknown etiology, characterized by noncaseating granulomas involving especially the lungs, reticuloendothelial system, eyes and skin. Although skin involvement has been reported in 9-37% of patients with sarcoidosis, isolated skin involvement has been reported in only 5.4%-13.8% of the cases. The purpose of this retrospective study was to evaluate the clinical and histopathological characteristics of patients with sarcoidosis and the relationship of cutaneous sarcoidosis with systemic sarcoidosis. Materials and Methods: Case records and histopathological files of 27 patients who were diagnosed with cutaneous sarcoidosis in our Dermatology and Venereology Department from 2005 to 2011 were retrospectively reviewed. Results: A total of 27 patients (22 female and 5 male) with a mean age 45 (12-69) years were evaluated. The mean duration of the disease was 1.5 years (1 month to 5 years). In 30% of patients, only skin lesions were found, and 19 patients (70%) had extracutaneous involvement. The distribution of specific types of skin lesions was plaque (12), nodules (10), papules (6), lupus pernio (4) and maculopapular rashes (1). The most common localization of the lesions was the head and neck region. One patient had an erythema nodosum lesion. Topical and systemic corticosteroids were used in eight patients with isolated skin lesions. Systemic, topical and intralesional corticosteroids and methotrexate were used in patients with extracutaneous involvement. In most of the patients, skin lesions were improved within 2-years follow-up period. Relapse was observed in 33% of patients. Conclusion: Cutaneous involvement can occur as the first sign of a systemic disease. According to our study results, 30% of our cases were characterized with isolated skin involvement. The signs of a systemic disease may accompany cutaneous sarcoidosis. Therefore, all patients presenting to the dermatology departments with cutaneous sarcoidosis require investigations for systemic sarcoidosis. (Turkderm 2013; 47: 148-54)

Özet

Amaç: Sarkoidoz; nedeni bilinmeyen, nonkazeifiye granülomatöz histopatolojisi olan, özellikle akciğer, retiküloendotelyal sistem, göz ve deriyi tutan multisistemik bir hastalıktır. Tüm sarkoidozlu olgularda deri tutulumu %9-37 oranında bildirilirken, sadece deri tutulumu %5,4-13,8 arasındadır. Bu retrospektif çalışmada amaç sarkoidozlu hastalarımızın klinikopatolojik özelliklerini ve kutanöz sarkoidoz ile sistemik sarkoidoz arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: 2005-2011 tarihleri arasında klinik ve patolojik olarak kutanöz sarkoidoz tanısı almış 27 hastanın tıbbi kayıtları geriye dönük olarak incelendi. Bulgular: Hastaların 22si kadın, 5i erkekti. Yaş ortalamaları 45 idi (12-69 arası). Hastalık süresi 1 ay-5 yıl (ort. 1,5 yıl) arasında değişmekteydi. Hastaların %30unda sadece deri tutulumu, 19unda (%70) ekstrakutanöz tutulum vardı. Sarkoidoz spesifik deri lezyon tiplerinin dağılımı plak (12), nodül (10), papül (6), lupus pernio (4), makülopapül (1) şeklindeydi ve lezyonların en çok yerleştiği alanlar baş-boyun bölgesi idi. Bir hastada eritema nodozum (EN) vardı. Sadece deri tutulumu olan 8 hastada topikal ve sistemik kortikosteroid, ekstrakutanöz tutulumu olan hastalarda sistemik, topikal ve intralezyoner kortikosteroid, metotreksat kullanıldı. Olgularımızın çoğunda 2 yıllık takip döneminde deri lezyonu düzelirken, %33ünde nüks gözlendi. Sonuç: Kutanöz tutulum sistemik hastalığın ilk bulgusu olarak ortaya çıkabilir. Çalışma verilerimize göre olgularımızın %30u sadece deri tutulumu ile karakterizedir. Kutanöz sarkoidal granülomlu hastalarda sistemik hastalık bulguları da eşlik edebilmektedir. Bu yüzden dermatoloji bölümüne başvuran tüm kutanöz sarkoidozlu hastalarda sistemik tutulumun araştırılması gerekir. (Türk­derm 2013; 47: 148-54)

🔖

Cite This Article

TUNALI, Ş., AYDOĞAN, K., AYDIN, Y., BÜLBÜL, E. B., TİLKİ, I. G., BALABAN, Ş. A., SARICAOĞLU, H. (2022). Retrospective analysis of 27 patients with cutaneous sarcoidosis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 47 - Sayı: 3, 148–154. https://ajindex.com/articles/621871

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mangas C, Fernández-Figueras MT, et al: Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis. J Cutan Pathol 2006;33:772-7.
  2. Güler E, Gülüş Demirel B, Kontaş O: Kutanöz sarkoidozlu 15 hastanın geriye dönük analizi. Turk J Dermatol 2011;5:66-70.
  3. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 1997;336:1224- 34. Jung YJ, Roh MR: Clinical and histopathological analysis of specific lesions of cutaneous sarcoidosis in Korean patients. J Dermatolog Treat 2010;22:11-7.
  4. Karaca N, Ertam İ, Kılınç Karaarslan I, Kazandı AC, Dereli T: Çiçek aşısı skarı üzerinde gelişen bir sarkoidoz olgusu. Türk Dermatoloji Dergisi 2007;1:27-8.
  5. Hunninghake G, Costabel U, Ando M, et al: Statement on sarcoidosis. AmRespir Crit Care Med 1999;126:736. Wolf K, Lowell AS, Katz I, et al: Fitzpatrick’s dermatology in general Medicine. 7th ed. New York: McGraw-Hill Co, 2008;1484-93.
  6. Costabel U, Ohshimo S, Guzman J. Diagnosis of sarcoidosis. Curr Opin Pulm Med 2008;14:455-61. No authors listed: Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
  7. Ali MM, Atwan AA, Gonzalez ML: Cutaneous sarcoidosis: updates in the pathogenesis. J Eur Acad Dermatol Venereol 2010;24:747-55.
  8. Collin B, Rajaratnam R, Lim R, Lewis H: A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department. Clin Exp Dermatol 2009;35:131-4.
  9. Chong WS, Tan HH, Tan SH: Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Exp Dermatol 2005;30:120-4.
  10. Mahajan VK, Sharma NL, Sharma RC, Sharma VC: Cutaneous sarcoidosis: clinical profile of 23 Indian patients. Indian J Dermatol Venereol Leprol 2007;73:16-21.
  11. Shetty AK, Gedalia A: Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila) 1998;37:707-17. English JC 3rd, Patel PJ, Greer KE: Sarcoidosis. J Am Acad Dermatol 2001;44:725-43. Elgart ML: Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 1986;4:35-45.
  12. Marcoval J, Mañá J, Rubio M: Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol 2011;36:739-44.
  13. Özşeker F, Bilgin S, Bayram Ü, et al: Sarkoidozda cilt tutulumu: 42 olgunun analizi. Solunum Has